ClinicalTrials.govpublic full text
Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
adult b acute lymphoblastic leukemia, adult b acute lymphoblastic leukemia with t(9;22)(q34;q11.2); bcr-abl1, recurrent adult acute lymphoblastic leukemia, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848134
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.